A genetic research program is proposed to investigate, in conjunction with cellular, molecular and biochemical analyses, the growth-promoting roles of insulin-like growth factors (IGFs) and growth hormone (GH), by using mutant mouse models that are either already available in the laboratory or will be generated by gene targeting. Recent evidence demonstrating the central involvement of the IGF system of ligands and receptors in embryonic and postnatal growth has provided a strong indication for the proposed project designed to address key questions on genetic components of the growth process that are related with cases of intrauterine growth retardation and a variety of dwarfing and overgrowth syndromes in humans. In the context of this program: (a) attempts will be made to elucidate the molecular nature of an unknown receptor (XR) previously identified genetically, which apparently mediates some of the growth-promoting functions IGF-II; (b) the hypothesis that XR may be the insulin receptor (IR) acting opportunistically in the absence of the type-1 IGF receptor (IGF1R) will be tested using double mutants lacking both IR and IGR1R; (c) the relative roles of IGF-I and IGF-II in embryonic growth will be examined in detail; (d) overgrowth phenotypes in mice lacking the type-2 IGF receptor or carrying a deletion that includes the Igf2-linked H19 gene will be analyzed; (e) the relationship between placental and embryonic growth will be assessed by embryo manipulations; (f) the relationship between GH and IGF-I in promoting postnatal growth will be investigated comparatively with emphasis on long-bone development, by targeted disruption of the GH receptor gene and by conditional ablation of the Igf1 gene in liver or in bones, to study the relative roles of circulating and locally-produced IGF-I; and (g) the role of the insulin receptor substrate-1 (IRS-1) in the IGF growth-signaling pathway(s) will be investigated genetically, while the identification of cDNAs encoding effectors of the same pathway will be sought through cell culture experiments utilizing cell lines lacking IGF1R, IR or both receptors. The genetic program that we propose should allow the establishment of causal relationships between defined mutations and their phenotypic consequences, and has the advantage that questions will be addressed in vivo in the context of the entire developing model organism.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD034526-02
Application #
2403620
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1996-08-16
Project End
2000-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Genetics
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Chiao, Eric; Fisher, Peter; Crisponi, Laura et al. (2002) Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling. Dev Biol 243:185-206
Lupu, F; Terwilliger, J D; Lee, K et al. (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-62
Dietrich, P; Dragatsis, I; Xuan, S et al. (2000) Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes. Mamm Genome 11:196-205
Efstratiadis, A (1998) Genetics of mouse growth. Int J Dev Biol 42:955-76
Morrione, A; Valentinis, B; Xu, S Q et al. (1997) Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc Natl Acad Sci U S A 94:3777-82
Eggenschwiler, J; Ludwig, T; Fisher, P et al. (1997) Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 11:3128-42
Louvi, A; Accili, D; Efstratiadis, A (1997) Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189:33-48